Effectiveness and feasibility of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

Background Delayed cerebral ischemia seriously affects the prognosis of patients surviving the initial aneurysmal subarachnoid hemorrhage. Application of cilostazol was reported to ameliorate vasospasm and improve outcomes in series and clinical trials. But the effectiveness and feasibility of cilos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology 2020-06, Vol.267 (6), p.1577-1584
Hauptverfasser:	Shan, Tikun, Zhang, Tiejun, Qian, Weiqiang, Ma, Lu, Li, Hao, You, Chao, Xie, Xiaoqi
Format:	Artikel
Sprache:	eng
Schlagworte:	Aneurysm Aneurysms Brain Ischemia - drug therapy Brain Ischemia - etiology Cardiovascular Agents - pharmacology Cerebral infarction Cerebral Infarction - drug therapy Cerebral Infarction - etiology Cilostazol - pharmacology Clinical trials Hemorrhage Humans Intracranial Aneurysm - complications Intracranial Aneurysm - drug therapy Ischemia Medicine Medicine & Public Health Meta-analysis Mortality Neurology Neuroradiology Neurosciences Nimodipine Outcome Assessment, Health Care Quality control Review Sensitivity analysis Stroke Subarachnoid hemorrhage Subarachnoid Hemorrhage - complications Subarachnoid Hemorrhage - drug therapy Subarachnoid Hemorrhage - etiology Systematic review Vasoconstriction Vasospasm, Intracranial - drug therapy Vasospasm, Intracranial - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!